Washington, DC – September, 12, 2012)  Galileo Analytics Co-Founder Anna McCollister-Slipp will be speaking at AdvaMed 2012, discussing the need for manufacturers to incorporate product data access and integration into the core elements of medical device design.

McCollister-Slipp will join other industry experts on a panel addressing the impact of regulation on the growing demand and use of health information technology, specifically as it relates to accessing and using device-generated data.

Complete panel information is below:

Impact of Health IT Regulations on Industry

Tuesday, October 2, 2012
9:15 am – 10:30 am
Panel Location: 160A 


Healthcare decision-makers are increasingly prioritizing Health IT, often at the expense of other budgets and even impacting the purchasing process of non-IT products. This poses a challenge for many medical device companies with limited Health IT experience or with a lack of familiarity with this rapidly evolving space. However, this also presents an opportunity for companies to use a forward-looking IT alignment strategy as a competitive advantage. Our panelists will highlight key examples of success and outline some demonstrated best practices.


  • Shami Feinglass MD, MPH, Vice President, Global Medical & Regulatory Affairs, Zimmer, Inc.


  • Anna McCollister-Slipp, Co-Founder, Galileo Analytics
  • Robert Jarrin, Senior Director, Government Affairs, Qualcomm Incorporated
  • Patricia Katzman, Director, Interoperability & CDS Marketing and Strategy, Philips Healthcare Patient Care & Clinical Informatics

Simon Fitall

About Simon Fitall

Simon is a knowledge engineer with 30 years experience in market research, data analytics and business intelligence within the pharmaceutical, biotechnology and medical device industries. With multiple patents in the field of advanced medical data analysis, Simon is an expert in data analysis with more than 20 years experience in working with, analyzing and creating models with patient data.

%d bloggers like this: